LncRNA Neat1 expedites the progression of liver fibrosis in mice through targeting miR-148a-3p and miR-22-3p to upregulate Cyth3

MicroRNA‐22‐3p alleviates spinal cord ischemia/reperfusion injury by modulating M2 macrophage polarization via IRF5

(2020) Hua Fang et al.   JOURNAL OF NEUROCHEMISTRY

Protective effects of microRNA‐22‐3p against retinal pigment epithelial inflammatory damage by targeting NLRP3 inflammasome

(2019) Zizhong Hu et al.   JOURNAL OF CELLULAR PHYSIOLOGY

LncRNA: Shedding light on mechanisms and opportunities in fibrosis and aging

(2019) Zhi Yang et al.   AGEING RESEARCH REVIEWS

miR‐148a suppresses inflammation in lipopolysaccharide‐induced endometritis

(2019) Kangfeng Jiang et al.   JOURNAL OF CELLULAR AND MOLECULAR MEDICINE

The lncRNA NEAT1/miR-29b/Atg9a axis regulates IGFBPrP1-induced autophagy and activation of mouse hepatic stellate cells

(2019) Yangyang Kong et al.   LIFE SCIENCES

MicroRNAs in the pathogenesis and treatment of progressive liver injury in NAFLD and liver fibrosis

(2018) Qiaozhu Su et al.   ADVANCED DRUG DELIVERY REVIEWS

TUG1 is involved in liver fibrosis and activation of HSCs by regulating miR-29b

(2018) Xiaohui Han et al.   BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS

MicroRNA-21 and Dicer are dispensable for hepatic stellate cell activation and the development of liver fibrosis

(2018) Jorge Matias Caviglia et al.   HEPATOLOGY

Sphingosine kinase 1 promotes liver fibrosis by preventing miR-19b-3p-mediated inhibition of CCR2

(2018) Tian Lan et al.   HEPATOLOGY

MiR-340 affects gastric cancer cell proliferation, cycle, and apoptosis through regulating SOCS3/JAK-STAT signaling pathway

(2018) Chunhong Xiao et al.   IMMUNOPHARMACOLOGY AND IMMUNOTOXICOLOGY

EZH2 promotes hepatocellular carcinoma progression through modulating miR-22/galectin-9 axis

(2018) Shaofei Chen et al.   JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH

Matrix metalloproteinase functions in hepatic injury and fibrosis

(2018) Martin Roderfeld   MATRIX BIOLOGY

MicroRNA-214 promotes hepatic stellate cell activation and liver fibrosis by suppressing Sufu expression

(2018) Liping Ma et al.   Cell Death & Disease

Preliminary screening and functional analysis of circular RNAs associated with hepatic stellate cell activation

(2018) Yuping Zhou et al.   GENE

MicroRNA-378 Promotes Hepatic Inflammation and Fibrosis via Modulation of the NFκB-TNFα Pathway

(2018) Tianpeng Zhang et al.   JOURNAL OF HEPATOLOGY

Liver fibrosis: Pathophysiology, pathogenetic targets and clinical issues

(2018) Maurizio Parola et al.   MOLECULAR ASPECTS OF MEDICINE

Inhibition of miR-148a-3p resists hepatocellular carcinoma progress of hepatitis C virus infection through suppressing c-Jun and MAPK pathway

(2018) Yibin Deng et al.   JOURNAL OF CELLULAR AND MOLECULAR MEDICINE

H19/miR-148a/USP4 axis facilitates liver fibrosis by enhancing TGF-β signaling in both hepatic stellate cells and hepatocytes

(2018) Jie Zhu et al.   JOURNAL OF CELLULAR PHYSIOLOGY

The roles of lncRNA in hepatic fibrosis

(2018) Hu Peng et al.   Cell and Bioscience

Insight into long noncoding competing endogenous RNA networks in hepatic fibrosis: The potential implications for mechanism and therapy

(2018) Ben-Sheng Dong et al.   GENE

Liver inflammation and fibrosis

(2017) Yukinori Koyama et al.   JOURNAL OF CLINICAL INVESTIGATION

Targeting noncoding RNAs in disease

(2017) Brian D. Adams et al.   JOURNAL OF CLINICAL INVESTIGATION

NEAT1 accelerates the progression of liver fibrosis via regulation of microRNA-122 and Kruppel-like factor 6

(2017) Fujun Yu et al.   JOURNAL OF MOLECULAR MEDICINE-JMM

The liver-enriched lnc-LFAR1 promotes liver fibrosis by activating TGFβ and Notch pathways

(2017) Kun Zhang et al.   Nature Communications

Butyrate induces ROS-mediated apoptosis by modulating miR-22/SIRT-1 pathway in hepatic cancer cells

(2017) Kishor Pant et al.   Redox Biology

TGF-β-induced hepatocyte lincRNA-p21 contributes to liver fibrosis in mice

(2017) Xiaolong Tu et al.   Scientific Reports

Differentiation therapy for hepatocellular carcinoma: Multifaceted effects of miR-148a on tumor growth and phenotype and liver fibrosis

(2016) Kwang Hwa Jung et al.   HEPATOLOGY

Endogenous microRNA sponges: evidence and controversy

(2016) Daniel W. Thomson et al.   NATURE REVIEWS GENETICS

Liver fibrosis and hepatic stellate cells: Etiology, pathological hallmarks and therapeutic targets

(2016) Chong-Yang Zhang et al.   WORLD JOURNAL OF GASTROENTEROLOGY

miR-22 targets YWHAZ to inhibit metastasis of hepatocellular carcinoma and its down-regulation predicts a poor survival

(2016) Ming Chen et al.   Oncotarget

MALAT1 functions as a competing endogenous RNA to mediate Rac1 expression by sequestering miR-101b in liver fibrosis

(2015) Fujun Yu et al.   CELL CYCLE

MiR-22 Suppresses BMP7 in the Development of Cirrhosis

(2015) Dong Ji et al.   CELLULAR PHYSIOLOGY AND BIOCHEMISTRY

Alcohol directly stimulates epigenetic modifications in hepatic stellate cells

(2015) Agata Page et al.   JOURNAL OF HEPATOLOGY

The multilayered complexity of ceRNA crosstalk and competition

(2014) Yvonne Tay et al.   NATURE

Non-coding RNAs as direct and indirect modulators of epigenetic regulation

(2013) Veronica J Peschansky et al.   Epigenetics

miR-148a plays a pivotal role in the liver by promoting the hepatospecific phenotype and suppressing the invasiveness of transformed cells

(2013) Luc Gailhouste et al.   HEPATOLOGY

microRNA-22, downregulated in hepatocellular carcinoma and correlated with prognosis, suppresses cell proliferation and tumourigenicity

(2010) J Zhang et al.   BRITISH JOURNAL OF CANCER